Received Feb 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
Patient reported that the 1st time they started developing skin issues (atopic dermatitis) was within about two months after receiving their 2nd dose of the Moderna COVID-19 vaccination. They now require use of over the counter and prescription medications to manage atopic dermatitis. The vaccinations were received at a local pharmacy (not the pharmacy of the reporting RPH) on an unknown date. Patient unable to provide additional specifics on the vaccine details at time of reporting. Any follow-up on this report should be completed by calling the patient directly.